Stony Brook Cancer Center Breast Cancer Research Retreat
March 7, 2014 • 8am-4pm
Hilton Garden Inn Stony Brook
Click here for photos from the event
RETREAT AGENDA | |
8:00-9:00am | Breakfast |
9:00-9:10am | Welcome Yusuf Hannun, MD, Director, Stony Brook Cancer Center |
9:10-10:10am | Session I: BREAST CANCER BIOLOGY AND SIGNALING (Chair: Christine Rizk, MD) Michael Frohman: Role of the Signaling Enzyme Phospholipase D1 in Breast Cancer Natalia Marchenko, PhD: Mutant p53 and Her2 Conspire to Expand Mammary Stem cells: Implications for Breast Cancer Therapy Michael Hayman, PhD: Prodrugs Targeting Histone Deacetylases and Proteases in Cancer |
10:10-11:10am | Session II: BREAST CANCER PATHOLOGY, EPIDEMIOLOGY AND EARLY DETECTION (Chair: Janice Lu, MD, PhD) Kenneth Shroyer, MD, PhD: 1. Discovery of Cytokeratin 17 as a Biomarker of Triple Negative Breast Cancer 2. Pathology Department Resources for Basic and Translational Research Barbara Nemesure: A Proposal for a Women’s High Risk Cancer Program Paul Fisher: Dual Energy Tomosynthesis |
11:10-11:20am | Break |
11:20am-12:40pm | Session III: TRANSLATIONAL RESEARCH - BENCH TO BEDSIDE (Chair: Jian Cao) Nurit Ballas: The Function of the Transcriptional Repressor REST as Tumor Suppressor in the Mammary Glands Hsien-Yu Wang: Targeting Frizzled-7 Signaling in Triple Negative Breast Cancer Evguenia Alexandrova: p63 as a Novel Regulator of HER2-positive Breast Cancer Gerald Thomsen: Evaluating a Novel GTPase as a Potential Breast Cancer Therapeutic Target |
12:40-1:30pm | Lunch |
1:30-2:50pm | Session IV: BREAST CANCER CLINICAL RESEARCH (Chair: Brian O’Hea, MD) Jules Cohen, MD: To be FDG or not to be FDG: PET/MRI and the study of chemobrain Marian Evinger: Nicotine Activates Mammary Cell Signaling Pathways: Establishing the Link Between Smoking and Breast Cancer Tamara Weiss, MD: Intraoperative Radiation Therapy for Breast Cancer Brian O’Hea, MD: Breast Cancer Update |
2:50-3:00pm | Closing Remarks (Lina Obeid) |
3:00-4:00pm | Poster Session (coffee and snacks) |